Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Cash & Equivalents (2016 - 2025)

Innovate has reported Cash & Equivalents over the past 16 years, most recently at $112.1 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 129.71% year-over-year to $112.1 million; the TTM value through Dec 2025 reached $112.1 million, up 129.71%, while the annual FY2025 figure was $112.1 million, 129.71% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $112.1 million at Innovate, up from $35.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $112.1 million in Q4 2025 and troughed at $16.6 million in Q1 2023.
  • A 5-year average of $47.3 million and a median of $41.9 million in 2021 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 263.76% in 2021 and later tumbled 58.35% in 2025.
  • Year by year, Cash & Equivalents stood at $45.5 million in 2021, then surged by 76.7% to $80.4 million in 2022, then rose by 0.5% to $80.8 million in 2023, then crashed by 39.6% to $48.8 million in 2024, then skyrocketed by 129.71% to $112.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for VATE at $112.1 million in Q4 2025, $35.5 million in Q3 2025, and $33.4 million in Q2 2025.